Clinical Trial Update: A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment [Phase 4]

View source ↗

Summary

A completed Phase 4 study comparing QUTENZA (capsaicin 8% patch) with pregabalin for peripheral neuropathic pain over 8 weeks, including non-diabetic peripheral…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-diabetic Peripheral Neuropathy
• Peripheral Nerve Injury
• Postherpetic Neuralgia

Drugs mentioned

• Pregabalin (Pregabalin)
• QUTENZA (Capsaicin)

Snippet

Sponsor: Astellas Pharma Europe Ltd. | Conditions: Non-diabetic Painful Peripheral Polyneuropathy, Postherpetic Neuralgia (PHN) | Phase 4 | Status: COMPLETED